During the current grant period, CCSG developmental funds were used to support the mission of the Cancer Center in 2 categories critical to the advancement of its goals: 1) additional faculty recruitment in disciplines related to the strategic vision of the Center and 2) pilot project grants to stimulate cross-disciplinary research involving population science. Both categories have proven rich opportunities for the Center to strengthen and diversify its research portfolio. Funds requested to support faculty recruitment in strategic areas have enabled the Center to attract top talent by providing a start-up/transition package that has enabled 8 new recruits to have the resources to immediately develop their research programs. Since their arrival at MSK, these 8 investigators have received $23.8M in peer-reviewed funding and produced over 25 manuscripts from their laboratories. Funds requested to support cross-disciplinary pilot projects involving PSR and other Center programs supported 16 projects, covering the broad spectrum of areas of population research that characterize the PSR Program, with multiple awards in each of PSR?s major programmatic themes: 1) cancer etiology and risk; 2) health behavior and symptom control; and 3) health care delivery, access and disparities. The projects were multidisciplinary as a requirement, and in many cases creative cross-disciplinary interactions were formed, matching population scientists with basic laboratory investigators or clinical investigators. Results have been exciting, with 3 of our junior investigators receiving their first NIH grants as a result of the pilot funds provided by this program. To date, 8 peer-reviewed grants have been awarded stemming from the research conducted in these pilot projects (4 NCI, 2 other NIH, 2 ACS). The total direct cost from these grants is $8,816,229. Building on the success in the current grant period, the Center proposes to continue its program in PSR Pilot Project Funding. We also propose a second faculty recruitment initiative to support the recruitment and integration of faculty with expertise in computational biology. This initiative will build on recent, strategic infrastructure investments in computational biology made by MSK.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-53
Application #
9631258
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
53
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Schlappe, Brooke A; Weaver, Amy L; Ducie, Jennifer A et al. (2018) Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy. Gynecol Oncol 151:235-242
Pareja, Fresia; Da Cruz Paula, Arnaud; Murray, Melissa P et al. (2018) Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults. J Clin Pathol :
Yao, Zhan; Gao, Yijun; Su, Wenjing et al. (2018) RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling. Nat Med :
Dumane, Vishruta A; Saksornchai, Kitwadee; Zhou, Ying et al. (2018) Reduction in low-dose to normal tissue with the addition of deep inspiration breath hold (DIBH) to volumetric modulated arc therapy (VMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiation. Radiat Oncol 13:187
Turashvili, Gulisa; Fix, Daniel J; Soslow, Robert A et al. (2018) Wilms Tumor of the Ovary: Review of the Literature and Report of 2 Cases. Int J Gynecol Pathol :
Krantz, Benjamin A; O'Reilly, Eileen M (2018) Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality? Clin Cancer Res 24:2241-2250
Chowell, Diego; Morris, Luc G T; Grigg, Claud M et al. (2018) Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science 359:582-587
Morgani, Sophie M; Metzger, Jakob J; Nichols, Jennifer et al. (2018) Micropattern differentiation of mouse pluripotent stem cells recapitulates embryo regionalized cell fate patterning. Elife 7:
Senders, Max L; Que, Xuchu; Cho, Young Seok et al. (2018) PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis. J Am Coll Cardiol 71:321-335
Fang, Jing; Muto, Tomoya; Kleppe, Maria et al. (2018) TRAF6 Mediates Basal Activation of NF-?B Necessary for Hematopoietic Stem Cell Homeostasis. Cell Rep 22:1250-1262

Showing the most recent 10 out of 8799 publications